Industry update CaaMTech close to winning patent to combine weed and psychedelics The Washington State-based biotech startup's application covers a range of cannabinoids and psilocybin compounds Jared GnamFebruary 10, 2021
The weed wire Psychedelic treatment firm enters NIH research deal CaaMTech will be researching synthetic tryptamine-based compounds as part of a cooperative R&D program Nick LabaMay 7, 2020